Show Menu
Influencing policy

Influencing policy

MEDFASH draws on the learning from its projects and involvement with a wide range of stakeholders to influence policy at national and local level.

We participate in campaigns, respond to consultations and produce briefings often in partnership with other sexual health and HIV organisations.

HPV action: It's time to vaccinate boys against HPV infection

HPV Action is a collaborative partnership of patient and professional organisations that advocates HPV vaccination for both boys and girls. HPV Action’s membership has grown from 2 to 33 in little over a year reflecting the fast-growing and now widespread support for gender-neutral vaccination.

On 12 November 2014, the Joint Committee on Vaccination and Immunisation (JCVI) advised (in an interim statement)  that a 'programme for the vaccination of MSM aged 16 to 40 years of age should be implemented in GUM and HIV clinics in the UK using the quadrivalent HPV vaccine, subject to the programme being provided at a cost-effective price'.

HPV Action welcomes this as a step forward in the campaign but believes that it does not go far enough.

See the HPV Action response to the JCVI interim statement (November 2014)

In September 2014, UK parliamentarians released a statement supporting the HPV Action campaign for HPV vaccination for both boys and girls.

See the parliamentarians statement (September 2014)
See the press release

Sex and Relationships Education

MEDFASH is a member of the Sex Education Forum (SEF) and was a signatory on a letter, coordinated by the SEF, signed by 69 experts and published in The Daily Telegraph on 4 September 2013 calling on the government to update its SRE guidance, which is 13 years old.

BHIVA and EAGA position statement on the use of antiretroviral therapy to reduce HIV transmission: January 2013

Our Chief Executive is a member of the Expert Advisory Group on AIDS (EAGA) and co-author of a position statement developed by EAGA with the British HIV Association (BHIVA) on the evidence for HIV treatment as prevention. The statement is designed to help clinicians and health promoters translate the evidence and thus support patients to make an informed decision about starting treatment based on their individual circumstances.

Read the full statement here.

Joint briefing on sexual and reproduction health and HIV 

View our joint briefing on sexual and reproductive health and HIV for local authorities and Health and Wellbeing Boards.

Halve It campaign

Find out about our involvement in the Halve It campaign which aims to halve the rates of undiagnosed and late diagnosed HIV.